case study Case Study: Boosting product confidence of a world-leading RNA therapeutics start-up CSIRO’s Transformational Bioinformatics group validates the importance of long non-coding RNAs (lncRNAs) as novel cancer therapeutics targets. The ClientAmaroq Therapeutics is a New Zealand-based biotechnology company targeting long non-coding RNAs for next
